A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

Andrés Muñoz MartinCihan AyElla GrilzSonia LópezCarme FontVanesa PachónVictoria CastellónVirginia Martínez-MarínMercedes SalgadoEva MartínezJulia Calzas Laura Ortega Ana Rupérez Eduardo SalasIngrid PabingerJosé Manuel Soria

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

The ONCOTHROMB score for VTE risk in outpatients with cancer, which takes into account both clinical and genetic variables, better identifies patients who might benefit from primary thromboprophylaxis than does the Khorana score.

Keyphrases

venous thromboembolism
genome wide
direct oral anticoagulants
papillary thyroid
copy number
squamous cell
childhood cancer